Navigation Links
Pediatric flu vaccination: Understanding low acceptance rates could help increase coverage
Date:4/28/2011

A study of H1N1 and seasonal influenza vaccination in a sample of black and Hispanic children in Atlanta found a low rate of vaccine acceptance among parents and caregivers. Only 36 percent of parents and caregivers indicated they would immunize children against H1N1, and 22 percent indicated their children received the seasonal influenza vaccine in the previous three months. The majority of children in the sample (71 percent) were from households with less than $40,000 in annual income.

Researchers say this low level of vaccine coverage and acceptance highlights the importance of understanding individual and community concerns that influence parents' decisions to have their children vaccinated.

The study is published in the Vaccine Safety Supplement of the April issue of the journal Pediatrics.

Children aged six months through 18 years, and caregivers of children younger than six months, were among the stated high-priority groups for the 2009 H1N1 vaccine. More recently, the ACIP has recommended that all persons older than six months should be vaccinated annually against influenza.

The study found that parents who said they were concerned about influenza, were concerned about H1N1 disease, and had confidence in vaccines and their preventive abilities were more likely to accept vaccination.

Although income did not correlate with vaccine acceptance, parents without health insurance were more likely to say they would vaccinate their children against H1N1 than were parents with insurance. The authors speculated this is due to concern related to treatment cost among parents without insurance.

Safety issues were generally not cited as a factor influencing decisions, but perceived greater risk of exposure and illness for children from the H1N1 virus was cited as a reason for those accepting vaccination. Other factors contributing to acceptance included lack of confidence in the effectiveness of hand washing, masks, and quarantine approaches over the H1N1 vaccine as prevention methods, and having a desire to promote influenza vaccination in the community.

"The well-publicized risks to children of contracting the H1N1 virus may have outstripped vaccine safety concerns in this case," notes lead author Paula Frew, PhD. "This shows that more comprehensive education of minority parents with regard to disease risk may provide a boost to vaccination rates." Frew is assistant professor of medicine and director of community research in Emory University School of Medicine.

"Physicians have a central community leadership role in educating parents about the importance of influenza vaccination" the authors write. "Moreover, our study results show parental confidence in the health departments to provide influenza vaccination compared with other community-based venues."

"Physician support of vaccination can help increase vaccine coverage, and community health departments are ideal locations for vaccine administration," says Frew.


'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Related medicine news :

1. Success of First World Congress of Pediatric Urology underscores increasing importance of specialty
2. Pediatricians Urge Better Protection From Chemicals
3. Scientific session and new research highlights from the American Society of Pediatric Otolaryngology Meeting
4. Nations pediatric otolaryngologists to convene in Chicago, April 27-May 1
5. UT Southwestern pediatricians launch landmark childrens health study
6. Treating newborn horses: A unique form of pediatrics
7. Pediatrics Group Offers Guidelines to Keep Young Campers Safe, Healthy
8. Childrens health is focus of annual meeting of Pediatric Academic Societies
9. Stephen J. Teach, MD, MPH, part of landmark study on pediatric asthma
10. Depolarizing the debates about pediatric mental health diagnosis and treatment
11. New mouse model explains common pediatric brain tumor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, ... residential and commercial clients in the northern Alabama and Georgia regions, is embarking ... Since 1977, Nobis Works has built a network of support and education facilities ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students attending Envision’s ... unique opportunity to get hands-on experience in an emergency medical simulation, When Care ... to gain invaluable, real-life medical skills that are critical success in a future ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the drug in their bodies, a researcher at the Icahn School of Medicine ... Research. , The study found that when young children are exposed to secondhand ...
(Date:12/7/2016)... PHILADELPHIA, PA (PRWEB) , ... December 07, 2016 ... ... story of a women growing up with a schizophrenic mother in a unique, ... social worker who specializes in treating trauma and addictive disorders at her private ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... YORK , December 8, 2016 ... focused on the research, distribution, and marketing of pharmaceutical ... affected by patent protection and expiration. Additionally, these firms ... Healthcare sector as a whole. Up for review this ... ), Synergy Pharmaceuticals Inc. (NASDAQ: SGYP ), ...
(Date:12/8/2016)... DES MOINES, Iowa , Dec. 8, 2016 ... STLT), a pharmaceutical company advancing technologies designed to ... the appointment of Chitra Edwin , Ph.D., ... and Compliance. Dr. Edwin will provide leadership for ... planning for regulatory approvals, preparation of regulatory submissions, ...
(Date:12/7/2016)... , Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial ... 37 biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar ... Japan , Kenya , ... , China , Slovakia , ... & 2 diabetes mellitus. The patent on Lantus expired in 2014. ...
Breaking Medicine Technology: